|
|
Volumn 146, Issue 12, 2007, Pages 829-838
|
|
Adalimumab induction therapy for Crohn disease previously treated with infliximab: A randomized trial
a
e
UNIV LILLE
(France)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADALIMUMAB;
ANTIBIOTIC AGENT;
AZATHIOPRINE;
BUDESONIDE;
INFLIXIMAB;
MERCAPTOPURINE;
MESALAZINE;
METHOTREXATE;
PLACEBO;
PREDNISONE;
MONOCLONAL ANTIBODY;
TUMOR NECROSIS FACTOR ALPHA;
ABDOMINAL ABSCESS;
ABDOMINAL PAIN;
ADULT;
AGED;
ANAMNESIS;
ARTHRALGIA;
ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROHN DISEASE;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG TOLERANCE;
DRUG WITHDRAWAL;
FATIGUE;
FEMALE;
GEOGRAPHIC DISTRIBUTION;
HEADACHE;
HUMAN;
INJECTION SITE BLEEDING;
INJECTION SITE CONTUSION;
INJECTION SITE ERYTHEMA;
INJECTION SITE IRRITATION;
INJECTION SITE PAIN;
INJECTION SITE PRURITUS;
INJECTION SITE REACTION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PELVIS ABSCESS;
PERIANAL ABSCESS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REMISSION;
SEPSIS;
STAPHYLOCOCCUS INFECTION;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
ADOLESCENT;
DRUG ANTAGONISM;
MIDDLE AGED;
PROSPECTIVE STUDY;
TREATMENT FAILURE;
ADOLESCENT;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL;
CROHN DISEASE;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
REMISSION INDUCTION;
TREATMENT FAILURE;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 34347402306
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-146-12-200706190-00159 Document Type: Article |
|
Times cited : (913)
|
|
References (29)
|
